Bausch Health Companies (BHC) FCF Margin (2009 - 2026)
Bausch Health Companies (BHC) posted FCF Margin of 20.79% for Q2 2026, up 333.72% sequentially from 4.79% in Q1 2026, and up 1328.0% YoY from 1.46% in Q2 2025.
Bausch Health Companies (BHC) FCF Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported FCF Margin for 18 years, with the latest figure at 20.79% in Q2 2026.
- Quarterly FCF Margin rose 1328.0% year-over-year to 20.79% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 13.19% (up 187.0% YoY) and the FY2025 annual result came in at 9.77%, down 332.0% from the prior year.
- FCF Margin grew to 20.79% in Q2 2026 per BHC's latest filing, from 4.79% in the prior quarter.
- Over five years, FCF Margin peaked at 20.79% in Q2 2026 and troughed at 64.37% in Q3 2022.
- A 5-year average of 5.75% and a median of 9.47% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2023: FCF Margin slumped 8810 bps in 2022, then soared 7509 bps in 2023.
- Over 5 years, FCF Margin stood at 18.65% in 2022, then sank by 35 bps to 12.13% in 2023, then soared by 60 bps to 19.34% in 2024, then decreased by 25 bps to 14.41% in 2025, then soared by 44 bps to 20.79% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 20.79%, 4.79%, and 14.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn | 20.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.79% |
| Mar 31, 2026 | 4.79% |
| Dec 31, 2025 | 14.41% |
| Sep 30, 2025 | 11.71% |
| Jun 30, 2025 | 7.51% |
| Mar 31, 2025 | 4.25% |
| Dec 31, 2024 | 19.34% |
| Sep 30, 2024 | 13.31% |
| Jun 30, 2024 | 12.57% |
| Mar 31, 2024 | 5.99% |
| Dec 31, 2023 | 12.13% |
| Sep 30, 2023 | 10.72% |
| Jun 30, 2023 | 8.21% |
| Mar 31, 2023 | 5.50% |
| Dec 31, 2022 | 18.65% |
| Sep 30, 2022 | -64.37% |
| Jun 30, 2022 | 3.61% |
| Mar 31, 2022 | -5.68% |
| Dec 31, 2021 | -0.75% |
| Sep 30, 2021 | 23.73% |